On-premise / private-cloud manufacturing execution system providing master-batch-record-driven electronic batch recording and shop-floor execution for GxP-regulated pharmaceutical and biotech producers. Native integration with Siemens SIMATIC PCS 7 / SIMATIC Batch distributed control systems, and a vendor-supplied GAMP-aligned validation package.
Opcenter Execution Pharma (abbreviated Opcenter EX PH) is Siemens' pharma-specific MES, formerly branded SIMATIC IT eBR. The current release stream is calendar-versioned (Opcenter EX PH 2025 / 2411 / 2505) succeeding the legacy semantic versions (6.1, 6.2.2, 6.2.3). The underlying workflow/execution engine was acquired in 2009 from Elan Software Systems (product "XFP") and incorporated into SIMATIC IT eBR. Siemens' 2014 acquisition of Camstar is sometimes cited as the genesis of the pharma MES, but Camstar's lineage folded into Opcenter Execution for medical device/semiconductor/electronics, while the pharma eBR product traces principally to Elan/XFP and SIMATIC IT.
Opcenter EX PH targets primary manufacturing — API synthesis, formulation, sterile fill-finish, biologics upstream/downstream — where electronic batch records, electronic signatures, and forward/backward material genealogy are non-optional for batch release. The platform is built around a Master Batch Record (MBR) concept: authorized users design MBRs graphically with parameter management and re-usable sub-process libraries, and the system automatically generates the executed eBR for each production order. Review-by-exception, deviation management, and equipment logbook are core OOTB capabilities.
Native, designed-in linkage connects the product to Siemens' own automation stack — SIMATIC PCS 7, SIMATIC Batch, WinCC HMI/SCADA — exposed via OPC and OPC UA. For plants whose Level 1/2 automation is Siemens, this removes a custom integration layer that plants running other automation platforms must build separately.
Recent releases (2411 in late 2024; 2505 in 2025) have moved more of the UX toward a web/Mendix-rendered Operator Cockpit, added an integrated alerts panel, added in-process control / at-line testing tied to Opcenter Laboratory, extended weighing and dispensing for cloud-deployed instances, and introduced PostgreSQL alongside Oracle. Opcenter EX PH is sold as part of the Siemens Xcelerator software portfolio. Although the campaign page references "eBR as a managed service" as a future direction enabled by Mendix low-code, the production product remains primarily an on-premise / customer-managed private-cloud deployment as of 2026-05-14 — not a Siemens-operated multi-tenant SaaS.
Pharmaceutical Edition
Opcenter Execution Pharma is the pharma-specific edition (formerly SIMATIC IT eBR). It is a dedicated SKU with embedded eBR, weigh-and-dispense, and native SIMATIC PCS 7 / SIMATIC Batch integration. Calendar-versioned releases (2411 in late 2024, 2505 in 2025) imply ~6-month cadence.
Core Capabilities
FDA & GxP Compliance
International Standards
Data Integrity & Validation
Primarily on-premise or customer-managed private cloud. Vendor describes weighing process "deployed in the cloud" in recent releases and references a future "eBR Apps Suite" / "managed service" via cloud infrastructure with low-code app development. A Siemens-operated multi-tenant SaaS edition is not the current production state.
Operator Cockpit is web-based (browser). SIMATIC HMI/SCADA-embedded task lists serve plant-floor terminals. Mobile-native client availability is unstated. SSO (SAML, OIDC, Azure AD, Okta) support is unstated. A REST API framework was added as a 6.2.3 enhancement, and the OPC UA client is native. Database support: Oracle (historical) plus PostgreSQL introduced in recent releases. Mendix low-code runtime is used to extend the Operator Cockpit and expand the role-based module catalog. Data residency is customer-controlled by virtue of on-prem / private-cloud deployment. ISA-88/ISA-95/B2MML alignment is not named as a supported standard, though SIMATIC Batch integration implies ISA-88 alignment at the DCS boundary. Throughput and concurrent-user benchmarks are undisclosed.
Not publicly listed by Siemens. Third-party sources describe a subscription per-user model with a $1,000+ per-user-per-month indicative rate (not vendor-confirmed). Historically Opcenter (and predecessor SIMATIC IT) was sold predominantly on perpetual license + annual maintenance; Siemens has shifted across its portfolio toward subscription. Per-named-user, per-site, and per-production-line elements are common in MES contracts; the exact Siemens metric mix is not publicly disclosed.
No public price list, rate card, or online configurator is published; all deals are sales-led. No public free trial is offered; demos are arranged through Siemens sales and partner channels. Industry convention for a single-site pharma MES program (software + SI + validation) places total program value at $1M+ for biotech single line, $3M+–$10M+ for mid-cap multi-line site, and $10M+–$50M+ for top-20 pharma multi-site rollouts. Independent TeepTrak analysis cites a 3-year TCO of $1.2M+–$3M+ for a 5-line secondary packaging site. Validation support typically delivered through SIs at $200–$350/hour blended consulting rates.
Implementation duration scales with site complexity. Directional ranges: small biotech / single line 6–12 months; mid-cap pharma single site 12–18 months; top-20 pharma multi-site rollout 18–24+ months per site with global rollouts 3–5+ years across the network. Independent analyst piece states "12 to 24 months of implementation during which the improvement velocity is frozen" for a 5-line site. Industry-wide, pharma MES projects have documented cost overruns and schedule slips, with schedule contingencies commonly running 25–50% over the initial SI bid and a parallel-paper "shadow" period typical during cutover.
Software license is the only Siemens-supplied direct purchase line. Implementation, MBR configuration, equipment/ERP integration, validation execution, and training are delivered through SI partners and billed separately. Named SI partners include AG Solution (Siemens-published implementation service partner), IndX (global MOM implementer with dedicated EX PH practice), and Snic Solutions (Siemens VAR). ATS Global, Capgemini, Accenture, Atos/Eviden, Cognizant, Wipro, and NNIT are commonly engaged on Siemens MOM pharma programs. Common pitfalls: MBR design complexity and tendency to encode every paper SOP literally; integration with non-Siemens automation (DeltaV, ControlLogix, Experion) adds significant configuration effort; Mendix low-code skillset on top of MES configuration lengthens team onramps; ~6-month release cadence requires regression strategy.
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
Strengths
Users on Gartner Peer Insights (Opcenter Execution platform level, blending pharma and non-pharma) report the platform is "a very good standard MES system" with "flexible platform for customization and complete manufacturing functionalities." OOTB capabilities purpose-built for process industry operations reduce time to value when leveraging defaults. Integration with Siemens automation infrastructure is reported as strong. Detailed audit trail history combined with flexible product configuration suits regulated production: "Extreme flexibility of product configuration coupled with detailed audit trail history made this perfect product for our Med device production." Siemens Gold Support and field-engineering staff are reported as knowledgeable.
Limitations & Open Questions
Users report bugs and "not intuitive" logic that create back-and-forth with the vendor: "Bugs and 'not intuitive' logic in the product, which necessitate a lot of back and forth to fully solved with the vendor." Heavy customization, especially non-pharma, creates upgrade challenges: "requires many customizations which in turn result in upgrade challenges." Installation and upgrade overhead is significant and frequently exceeds in-house plant teams' capacity. Pharma-specific implementation length (12+ months) is repeatedly flagged in third-party buyer guides as a downside.
Help the community
Share your experience with Siemens Opcenter Execution Pharma anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section